Compound class:
Synthetic organic
Comment: The chemical structure for this MRGPRX2 antagonist was revealed during the first disclosures session at the 2022 ACS meeting in Chicago. The orphan MRGPRX GPCRs are being investigated as potential drug targets for mast cell-mediated immune diseases [1-4].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Database Links ![]() |
|
GtoPdb PubChem SID | 472319274 |
PubChem CID | 164734529 |
Search Google for chemical match using the InChIKey | UOCITXUZOXOHLH-WMLDXEAASA-N |
Search Google for chemicals with the same backbone | UOCITXUZOXOHLH |
UniChem Compound Search for chemical match using the InChIKey | UOCITXUZOXOHLH-WMLDXEAASA-N |
UniChem Connectivity Search for chemical match using the InChIKey | UOCITXUZOXOHLH-WMLDXEAASA-N |